Almac Clinical Services has launched two new clinical trial supply systems that help to remove bottlenecks within the supply chain process with its new system of automated label verification. The Almac system was introduced following analysis of the current industry practice of 200% manual checking of both fixed and variable text on clinical trial study kit labels, and how lead time could be reduced.
According to the company, manual checking of study labels is no longer required with its new system, enhancing the speed of availability and providing a more robust audit trail. This label verification system is different in that variable content including randomization details are checked and verified by the system as well as industry standard fixed text checking.
The company has also introduced a fully automated modular over-encapsulation system for blinding of comparator products in clinical trials. With this system, individual tooling for each tablet shape/size is no longer required, resulting in improved timelines, according to the company.
Dr. Robert Dunlop, president, Almac Clinical Services, said, “We have identified bottlenecks that are common within the clinical supply chain and targeted our solutions to these two key areas. We are confident that our automated label verification system and new array of comparator blinding options will assist in ensuring trials are started on time and lead times are shortened to bring drug to market.”
Magazine
